- Pharmaxis Home
- About Us
- Our Products
- Investors
- News
- New Product Pipeline
- Contact Us
- Health Professionals
- Distributors
- Patients
Investor Information
ASX ANNOUNCEMENTS
- 11.03.2010 - Notice of Change of Interests of Substantial Holder
- 09.02.2010 - Appendix 3B - Topigen Acquisition
- 09.02.2010 - Disclosure notice under section 708A(5)(e) of the Corporations Act 2001 (Cth)
- 05.02.2010 - Appendix 3B - Exercise of Employee Options
Category:
ASX Announcements Archive: 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003
MEDIA RELEASES
- 11.03.2010 - Pharmaxis Completes Phase II clinical study with ASM8 in asthma patients
- 09.02.2010 - Pharmaxis completes clinical trial with the antifibrotic agent, PXS25
- 09.02.2010 - Pharmaxis completes acquisition of Canadian company Topigen Pharmaceuticals Inc
- 28.01.2010 - Recording of Investor Conference Call - 28 January 2010
Category:
Media Releases Archive: 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003
QUARTERLY REPORTS
- 27.01.2010 - Quarterly Report to Shareholders December 2009
- 14.10.2009 - Quarterly Report to Shareholders September 2009
- 22.07.2009 - Quarterly Report to Shareholders June 2009
- 08.04.2009 - Quarterly Report to Shareholders - March 2009
Category:
Page 1 of 2
1 2
1 2
Quarterly Reports Archive: 2009 | 2008 | 2007 | 2006 | 2005 | 2004